Old Web
English
Sign In
Acemap
>
authorDetail
>
Hsiu Ying Hung
Hsiu Ying Hung
Taipei Veterans General Hospital
Medicine
Internal medicine
Disease
Epidermal growth factor receptor
Tyrosine-kinase inhibitor
3
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer.
2020
PLOS ONE
Hsiu Ying Hung
Yen-Han Tseng
Heng-Sheng Chao
Chao Hua Chiu
Wen-Hu Hsu
Han-Shui Hsu
Yu-Chung Wu
T. Chou
Chun-Ku Chen
Keng-Li Lan
Yi-Wei Chen
Yuan-Hung Wu
Yuh-Min Chen
Show All
Source
Cite
Save
Citations (12)
The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment.
2017
Integrative Cancer Therapies
Hsiu Ying Hung
Yen-Han Tseng
Chia Miao Liao
Sung Yi Chen
Ta-Peng Wu
Yu Chin Lee
Yuh-Min Chen
Show All
Source
Cite
Save
Citations (7)
Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI)
2016
Journal of Chemotherapy
Yen-Han Tseng
Hsiu Ying Hung
Yi Chen Sung
Yen-Chiang Tseng
Yu-Chin Lee
Jacqueline Whang-Peng
Yuh-Min Chen
Show All
Source
Cite
Save
Citations (8)
1